References

1. Harrington WJ, Minnich V, Hollingsworth JW, Moore CV (1990) Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. 1951. J Lab Clin Med 115: 636-645 [Google Scholar] [PubMed]
2. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, et al. (2008). Standardization of terminology; definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2113: 2386-2393 [CrossRef] [PubMed]
3. Zeller B, Helgestad J, Hellebostad M, Kolmannskog S, Nystad T, et.al. (2000) Immune thrombocytopenic Purpura in Childhood in Norway: a prospective, population-based registration. Pediatr Haematol Oncol 17: 551-558 [CrossRef] [Google Scholar] [PubMed]
4. Nugent DJ (2006) Immune thrombocytopenic purpura of childhood. Hematology Am Soc Hematol Educ Program 97-103 [CrossRef] [Google Scholar] [PubMed]
5. British Committee for Standards in Haematology General Haematology Task Force (2003) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120: 574-596 [CrossRef] [Google Scholar] [PubMed]
6. Kühne T, Buchanan GR, Zimmerman S, Michaels LA, Kohan R, et al. (2003) A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental childhood ITP Study Group. J Pediatr 143: 605-608 [CrossRef] [Google Scholar] [PubMed]
7. Kühne T, Berchtold W, Michaels LA, Wu R, Donato H, et al. (2011) Intercontinental Cooperative ITP Study Group. Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group. Haematologica 96: 1831-1837 [CrossRef] [Google Scholar] [PubMed]
8. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, et al. (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117: 4190-4207 [CrossRef] [PubMed]
9. Saleh MN, Gutheil J, Moore M, Bunch PW, Butler J, et al. (2000) A pilot study of the anti-D monoclonal antibody rituximab in patients with refractory immune thrombocytopenia. SeminOncol 2: 99-103
10. Bussel JB, Buchanan GR, Nugent DJ, Gnarra DJ, Bomgaars LR, et al. (2011) A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia. Blood 118: 28-36 [CrossRef] [PubMed]
11. Sutor AH, Harms A, Kaufmehl K (2001) Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin Thromb Hemost 27: 253-267 [CrossRef] [Google Scholar] [PubMed]
12. Donato H, Picón A, Martinez M, Rapetti MC, Rosso A, et al. (2004) Demographic data, natural history, and prognostic factors of idiopathic thrombocytopenic purpura in children, a multicentered study from Argentina. Pediatr Blood Cancer 52: 491-496 [CrossRef] [Google Scholar] [PubMed]
13. Fogarty PF, Segal JB (2007) The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol 14: 515-519 [CrossRef] [Google Scholar] [PubMed]
14. Yong M, Schoonen WM, Li L, Kanas G, Coalson J, et al. (2010) Epidemiology of pediatric immune thrombocytopenia in the general practice research database. Br J Haematol149: 855-864 [CrossRef] [Google Scholar] [PubMed]
15. Jonville-Béra AP, Autret E, Galy-Eyraud C, Hessel L (1996) Thrombocytopenic purpura after mumps, measles and rubella vaccination: A retrospective survey by the French Regional Pharmcovigilance Centres and Pasteur-Merieux serums et vaccines. Pediatr Infect Dis J 15: 44-48 [CrossRef] [PubMed]
16. Beeler J, Varricchio F, Wise R (1996) Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990-1994). Pediatr Infect Dis J 15: 84-88 [CrossRef] [Google Scholar] [PubMed]
17. Hsieh Y I, Lin L H (2010) Thrombocytopenic purpura following vaccination in early childhood : experience of a medical center in the past two decades. J Chin Med Assoc 73: 634-637 [CrossRef] [Google Scholar] [PubMed]
18. Alam MM (2014) Idiopathic thrombocytopenic purpura in children: a 10 years experience at tertiary care hospital. J Pak Med Assoc 64: 1358-1362 [Google Scholar] [PubMed]
19. Kühne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, et al. (2001) For the International Childhood ITP Study Group. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 358: 2122-2155 [CrossRef] [Google Scholar] [PubMed]
20. Zeller B, Helgestad J, Hellebostad M, Kolmannskog S, Nystad T, et al. (2000) Immune thrombocytopenic Purpura in Childhood in Norway: a prospective, population-based registration. Pediatr Haematol Oncol 17: 551-558 [CrossRef] [Google Scholar] [PubMed]
21. Heitink-Pollé KM, Nijsten J, Boonacker CW, de Haas M, Bruin MC (2014) Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis. Blood 124: 3295-3307 [CrossRef] [PubMed]
22. Zeller B, Rajantie J, Hedlund-Treutiger I, Tedgård U, Wesenberg F, et al. (2005) Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr 94: 178-184 [CrossRef] [Google Scholar] [PubMed]
23. Kühne T, Buchanan GR, Zimmerman S, Michaels LA, Kohan R, et al. (2003) A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic hrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr; 143: 605 [CrossRef] [Google Scholar] [PubMed]
24. Sfaihi L, Kassar O, Medhaffar M, Kamoun T, Hadiji S, et al. (2014) [Primary immune thrombocytopenia in childhood: a regional study in the south of Tunisia]. Tunis Med 92: 219-223 [Google Scholar] [PubMed]
25. García-Stivalet LA, Muñoz-Flores A, Montiel-Jarquín AJ, Barragán-Hervella RG, Bejarano-Huertas R, et al. (2014) [Clinical analysis of 200 cases of idiopathic thrombocytopenic purpura]. Rev Med Inst Mex Seguro Soc 52: 322-325 [Google Scholar] [PubMed]
26. Medeiros D, Buchanan GR (1998) Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome.J Pediatr 1133: 334-339 [CrossRef] [Google Scholar] [PubMed]
27. Tarantino MD, Danese M, Klaassen RJ, Duryea J, Eisen M, et al. (2016) Hospitalizations in pediatric patients with immune thrombocytopenia in the United States. Platelets 27: 472-478 [CrossRef] [Google Scholar] [PubMed]
28. Zhou F, Xu Y, Zhang Z, Wu X, Jin R (2015) Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia. J Pediatr Hematol Oncol 37: e158-161 [CrossRef] [Google Scholar] [PubMed]
29. Moussalem M, Yassine N (2003) Immune thrombocytopenic purpura in childhood: a Lebanese perspective. Mol Immunol 39: 1105-1107 [CrossRef] [Google Scholar] [PubMed]
30. Flores A, Buchanan GR (2016) Occult hemorrhage in children with severe ITP. Am J Hematol 91: 287-290 [CrossRef] [Google Scholar] [PubMed]
31. Elalfy M, Elbarbary N, Khaddah N, Abdelwahab M, El Rashidy F, et al. (2010) Intracranial hemorrhage in acute and chronic childhood immune thrombocytopenic purpura over a ten-year period: an Egyptian multicenter study. Acta Haematol 123: 59-63 [CrossRef] [Google Scholar] [PubMed]
32. Sodhi PK, Jose R (2003) Subconjunctival hemorrhage: the first presenting clinical feature of idiopathic thrombocytopenic purpura. Jpn J Ophthalmol 47: 316-318 [CrossRef] [Google Scholar] [PubMed]
33. Jung JY, O AR, Kim JK, Park M (2016) Clinical course and prognostic factors of childhood immune thrombocytopenia: single center experience of 10 years. Korean J Pediatr 59: 335-340 [CrossRef] [Google Scholar] [PubMed]
34. Neunert C, Noroozi N, Norman G, Buchanan GR, Goy J, Nazi I, et al. (2015) Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost 13: 457-464 [CrossRef] [Google Scholar] [PubMed]
35. Kim CY, Lee EH, Yoon HS (2016) High Remission Rate of Chronic Immune Thrombocytopenia in Children: Result of 20-Year Follow-Up. Yonsei Med J 57: 127-131 [CrossRef] [Google Scholar] [PubMed]
36. Stefan DC , Gwessels G (2008) A survey of the management of idiopathic thrombocytopenic purpura in South Africa : Do we need guidelines for developing countries? SAJCH 2: 15-18 [Google Scholar]
37. Medeiros, Desiree, Buchanan, George R (2000) Idiopathic thrombocytopenic purpura: beyond consensus. Current Opnion in Pediatric 12: 4-9 [CrossRef] [Google Scholar] [PubMed]
38. Glanz J, France E, Xu S, Hayes T, Hambidge S (2008) A populationbased, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics 121: e506-512 [CrossRef] [Google Scholar] [PubMed]
39. Robb LG, Tiedeman K (1990) Idiopathic thrombocytopenic purpura: predictors of chronic disease. Arch Dis Child 65: 502-506 [CrossRef] [Google Scholar] [PubMed]
40. Al-Mulla N, Bener A, Amer A, Abu Laban M (2009) Idiopathic thrombocytopenic purpura in childhood : a population, based study in Qatar. J Pediatr (Rio J) 85: 269 -272 [CrossRef] [Google Scholar] [PubMed]